NCT03131089 (YBC) is a clinical trial in Breast Cancer, sponsored by Samsung Medical Center.

Who is sponsoring NCT03131089?

NCT03131089 is sponsored by Samsung Medical Center.

What condition does NCT03131089 study?

NCT03131089 studies Breast Cancer.

Is NCT03131089 still recruiting?

NCT03131089 is currently status unknown. Last updated 27 April 2017.

Last reviewed 2017-04-27 · How we verify

NCT03131089: YBC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Young Breast Cancer Cohort Study

Status unknown Last updated 27 April 2017

What this trial tests

trial in Breast Cancer in 2,000 participants. Status unknown.

Timeline

11 April 2013

Primary endpoint
17 February 2018

10 April 2023

Quick facts

Lead sponsor	Samsung Medical Center
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	2,000
Start date	11 April 2013
Primary completion	17 February 2018
Estimated completion	10 April 2023
Sites	1 location across South Korea

Conditions studied

Breast Cancer — all drugs for Breast Cancer →

Sponsor

Samsung Medical Center

Who can join

Under 40, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is prospective cohort study to investigate and identify comprehensively the clinicopathological features and long-term outcome of young breast cancer (YBC). We have enrolled Breast cancer patients under 40 year-old and collected their baseline characteristics including tumor character, familiar history and other background information. Moreover, we have collected breast cancer tissue/blood sample for analyzing genetic characteristics, if patient agree to genetic analysis.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Whole-genome landscapes of 1,364 breast cancers.
Kim R, Yu J, Lim J, Oh BB, et al · · 2026 · cited 1× · PMID 41339552 · DOI 10.1038/s41586-025-09812-3
Impact of Social Support during Diagnosis and Treatment on Disease Progression in Young Patients with Breast Cancer: A Prospective Cohort Study.
Kang D, Park S, Kim HJ, Kim SW, et al · · 2024 · PMID 37669709 · DOI 10.4143/crt.2023.673
Pretreatment endocrine symptoms and recurrence-free survival among young premenopausal patients with breast cancer: a prospective cohort study.
Kang D, Cho J, Park S, Kim HJ, et al · · 2023 · PMID 37547446 · DOI 10.1177/17588359231189421

Verify or expand the search:

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other Samsung Medical Center trials

Trials by the same sponsor.

NCT07482865 — Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support · NA · not yet recruiting
NCT07467213 — Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute M · Phase 4 · not yet recruiting
NCT07530913 — Effectiveness Analysis of a Rehabilitation Exercise Platform for Living Donor Liver Transplantation Patients · NA · enrolling by invitation
NCT07500701 — Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Pro · Phase 3 · recruiting
NCT07409441 — Korea Acute Myocardial Infarction Registry · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03131089 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Samsung Medical Center
Last refreshed: 27 April 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03131089.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing